Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate.

Published byJeremy Sanders Modified over 8 years ago

Similar presentations

Presentation on theme: "Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate."— Presentation transcript:

1 Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate VariablesβOR95%CIPβOR95%CIP Male sex1.9467.0002.655-18.4520.0002.60313.4983.043-59.8670.01 Age-0.0340.9670.925-1.0100.967 Diabetes0.4511.5700.652-3.7801.570 History of cardiovascular disease -0.0980.9070.330-2.4960.850 Smoking0.7902.2030.897-5.4120.085 ESA duration-0.0090.9910.962-1.0220.577 CRP0.0161.0160.809-1.2750.893 ΔLVMI0.0181.0180.999-1.0370.057 Δ hemoglobin0.0981.1030.805-1.5100.542 Δ Albumin0.1991.2210.404-3.6910.724 Δ Phosphate0.0341.0340.745-1.4360.840 Δ Systolic BP0.0151.0150.999-1.0310.060 Δ Diastolic BP0.0311.0320.999-1.0660.0550.0301.0311.003-1.0600.032 Δ, Degree of the change in variables between two time points. Abbreviations: ESA, erythropoiesis stimulating agents; CRP, C-reactive protein; LVMI, left ventricular mass Index; BP, blood pressure

2 All-cause mortality Cardiovascular mortality HR95%CIPHR95%CIP Univariate analysis Ln BNP1.1830.942-1.4860.1481.4560.946-2.2420.088 Multivariate analysis Model 10.9810.747-1.2880.8911.2730.730-2.2210.395 Model 20.8860.673-1.1660.3891.3090.716-2.3920.381 Model 31.0040.750-1.3430.9801.6650.849-3.2640.138 Model 1: adjusted for age, gender, diabetes, history of cardiovascular diseases, smoking Model 2: Model 1 + albumin, C-reactive protein Model 3: Model 2 + EF, LVMI Abbreviations: HR, hazard ratio; CI, confidence interval; BNP, brain natriuretic peptide; EF, ejection fraction; LVMI, left ventricular mass index; ln. natural logarithm Table S2. Univariate and multivariate Cox proportional hazards models

3 Overall survival Cardiovascular death-free survival 1 st tertile2 nd tertile 0.9221 3 rd tertile0.25810.2461 1 st tertile 2 nd tertile 3 rd tertile 1 st tertile2 nd tertile 0.8759 3 rd tertile0.12140.1706 Months on renal replacement therapy Probability of survival 1 st tertile 2 nd tertile 3 rd tertile

4 Supplementary Files Figure S1. Unadjusted Kaplan-Meier curves for overall and cardiovascular death-free survival according to BNP measured at dialysis initiation in the overall patient population (n = 248). Abbreviation: BNP, brain natriuretic peptide

Download ppt "Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate."

Similar presentations

Age (years) Gender (Males), n (%) Dialysis duration (years) Hemoglobin (mg / dl) Pre dialysis SBP (mmHg) Pre dialysis DBP(mmHg) Post dialysis SBP (mmHg)

Age (years) Gender (Males), n (%) Dialysis duration (years) Hemoglobin (mg / dl) Pre dialysis SBP (mmHg) Pre dialysis DBP(mmHg) Post dialysis SBP (mmHg)
Prevalence (%) Prevalence of CAC by Degree of cPB No Carotid Plaque cPB Tertile 1 cPB Tertile 2 cPB Tertile 3 (n=1,316) (n=1,498) (n=1,497) (n=1,497) Supplementary.

Prevalence (%) Prevalence of CAC by Degree of cPB No Carotid Plaque cPB Tertile 1 cPB Tertile 2 cPB Tertile 3 (n=1,316) (n=1,498) (n=1,497) (n=1,497) Supplementary.
PEACE BNP: Omland, T. et al. J Am Coll Cardiol 2007; 50:205–14 Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Prognostic.

PEACE BNP: Omland, T. et al. J Am Coll Cardiol 2007; 50:205–14 Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Prognostic.
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,

The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank.

Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.

To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.

Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Presenter Disclosure Information Echocardiographic Tissue Doppler Imaging Is a Powerful Independent Prognosticator of Overall Mortality in the General.

Presenter Disclosure Information Echocardiographic Tissue Doppler Imaging Is a Powerful Independent Prognosticator of Overall Mortality in the General.
Supplemental Table A. Baseline proteinuria predicting renal outcome in multivariable Cox-Hazard model PredictorsHR95% CIp value Baseline UPE, g/day2.311.31.

Supplemental Table A. Baseline proteinuria predicting renal outcome in multivariable Cox-Hazard model PredictorsHR95% CIp value Baseline UPE, g/day
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.

Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Serum Selenium Levels and All-Cause, Cancer, and.

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Serum Selenium Levels and All-Cause, Cancer, and.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prediction of Cardiac Events in Patients With Reduced.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prediction of Cardiac Events in Patients With Reduced.
Date of download: 6/22/2016 From: Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease:

Date of download: 6/22/2016 From: Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease:
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: BNP-Guided vs Symptom-Guided Heart Failure Therapy:

Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: BNP-Guided vs Symptom-Guided Heart Failure Therapy:
Date of download: 6/26/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Trends in Anemia Care in Older Patients Approaching.

Date of download: 6/26/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Trends in Anemia Care in Older Patients Approaching.
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.

Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.

Similar presentations

Ads by Google